|
|
 |
 |
 Sanguine brings FHIR to Patient Health Records Like the mythological Prometheus (with better outcomes for the hero), Sanguine is augmenting specimen collection with Fast Healthcare Interoperability Resources (FHIR) to shorten study timelines and offer new product opportunities.
Read the Press Release
|
|
|
|
 SLAS2024: Tackling variability and inefficiency in therapy development. Are you attending SLAS2024 in Boston February 5-7? Visit Booth 469 to discuss how prospective biospecimens and leukopaks can maximize automation ROI.
Book A Meeting
|
|
|
|
 Pick preferred specimens to perfect immune profiling Discover simple, underappreciated solutions to achieving more reliable flow cytometry data and adding longitudinal study design to your immune profiling studies.
Read the latest Blog
|
|
|
|
 Bridging translational and precision medicine Read how a direct-to-patient approach to prospective specimen collection addresses the translation gap in our latest white paper.
Read the Article
|
|
|
|
|
|
 |
Utilizing a human TLR selective ligand in a humanized immune system mouse model to investigate human TLR4 signaling Twomey, Graham, Spina, et al
J Biol Methods (2023) 10: jbm-10-e99010008 DOI: 10.14440/jbm.2023.408
Read more
|
|
 |
A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses Shahjahan Miah, Lelias, Gutierrez, et al
Front Immunol (2023) 14: 1290688 DOI: 10.3389/fimmu.2023.1290688
Read more
|
|
|
|
|
|
| To unsubscribe, click here. ©2024 Sanguine, 400 W Cummings Park, Suite 3050, Woburn, MA 01801
| https://sanguinebio.com |  | 818-462-8290 |
|
